Switch theme
Sign up to access all valuation multiples
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
2020
3.4K+
LTM Revenue $981M
LTM EBITDA $63.9M
$239M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Euroapi has a last 12-month revenue of $981M and a last 12-month EBITDA of $63.9M.
In the most recent fiscal year, Euroapi achieved revenue of $987M and an EBITDA of -$45.6M.
Euroapi expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Euroapi valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.1B | $987M | XXX | XXX | XXX |
| Gross Profit | $190M | $177M | XXX | XXX | XXX |
| Gross Margin | 17% | 18% | XXX | XXX | XXX |
| EBITDA | $76.3M | -$45.6M | XXX | XXX | XXX |
| EBITDA Margin | 7% | -5% | XXX | XXX | XXX |
| Net Profit | -$16.1M | -$204M | XXX | XXX | XXX |
| Net Margin | -1% | -21% | XXX | XXX | XXX |
| Net Debt | $27.5M | $184M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Euroapi's stock price is EUR 2 (or $3).
Euroapi has current market cap of EUR 232M (or $250M), and EV of EUR 222M (or $239M).
See Euroapi trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $239M | $250M | XXX | XXX | XXX | XXX | $-0.40 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Euroapi has market cap of $250M and EV of $239M.
Euroapi's trades at 0.2x LTM EV/Revenue multiple, and 3.7x LTM EBITDA.
Analysts estimate Euroapi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Euroapi and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $239M | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | -5.2x | XXX | XXX | XXX |
| P/E | -1.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 14.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpEuroapi's NTM/LTM revenue growth is -2%
Euroapi's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $47K for the same period.
Over next 12 months, Euroapi's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Euroapi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Euroapi and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -10% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -5% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -160% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -7% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $47K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 16% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
| Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
| Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
| Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
| Suven Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Euroapi acquired XXX companies to date.
Last acquisition by Euroapi was XXXXXXXX, XXXXX XXXXX XXXXXX . Euroapi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Euroapi founded? | Euroapi was founded in 2020. |
| Where is Euroapi headquartered? | Euroapi is headquartered in France. |
| How many employees does Euroapi have? | As of today, Euroapi has 3.4K+ employees. |
| Is Euroapi publicy listed? | Yes, Euroapi is a public company listed on PAR. |
| What is the stock symbol of Euroapi? | Euroapi trades under EAPI ticker. |
| When did Euroapi go public? | Euroapi went public in 2022. |
| Who are competitors of Euroapi? | Similar companies to Euroapi include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
| What is the current market cap of Euroapi? | Euroapi's current market cap is $250M |
| What is the current revenue of Euroapi? | Euroapi's last 12-month revenue is $981M. |
| What is the current EBITDA of Euroapi? | Euroapi's last 12-month EBITDA is $63.9M. |
| What is the current EV/Revenue multiple of Euroapi? | Current revenue multiple of Euroapi is 0.2x. |
| What is the current EV/EBITDA multiple of Euroapi? | Current EBITDA multiple of Euroapi is 3.7x. |
| What is the current revenue growth of Euroapi? | Euroapi revenue growth between 2023 and 2024 was -10%. |
| Is Euroapi profitable? | Yes, Euroapi is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
